Social stress induces neurovascular pathology promoting depression

Nature Neuroscience

Volumn 20, Issue 12, 2017, Pages 1752-1760

  Menard, Caroline ^a,g   Pfau, Madeline L ^a   Hodes, Georgia E ^a   Kana, Veronika ^a   Wang, Victoria X ^b   Bouchard, Sylvain ^a   Takahashi, Aki ^a,c   Flanigan, Meghan E ^a   Aleyasin, Hossein ^a   Leclair, Katherine B ^a   Janssen, William G ^a   Labonté, Benoit ^a   Parise, Eric M ^a   Lorsch, Zachary S ^a   Golden, Sam A ^a   Heshmati, Mitra ^a   Tamminga, Carol ^d   Turecki, Gustavo ^e   Campbell, Matthew ^f   Fayad, Zahi A ^b   Tang, Cheuk Ying ^b   Merad, Miriam ^a   Russo, Scott J ^a   more..

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Translational and Molecular Imaging Institute   (United States)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^f TRINITY COLLEGE DUBLIN   (Ireland)

^g UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 5; SHORT HAIRPIN RNA; ADRENERGIC RECEPTOR AFFECTING AGENT; CLDN5 PROTEIN, MOUSE; IMIPRAMINE; INTERLEUKIN 6; INTERLEUKIN-6, MOUSE; TIGHT JUNCTION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CELL INFILTRATION; CELL MEMBRANE PERMEABILITY; CLDN5 GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; MAJOR DEPRESSION; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; SOCIAL STRESS; ANIMAL; ANIMAL BEHAVIOR; ANXIETY; BIOSYNTHESIS; C57BL MOUSE; DEPRESSION; FEEDING BEHAVIOR; FOOD PREFERENCE; GENETICS; MENTAL STRESS; METABOLISM; PATHOLOGY; PSYCHOLOGY; SOCIAL ENVIRONMENT; SWIMMING;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BLOOD-BRAIN BARRIER; CLAUDIN-5; DEPRESSION; FEEDING BEHAVIOR; FOOD PREFERENCES; IMIPRAMINE; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; NUCLEUS ACCUMBENS; SOCIAL ENVIRONMENT; STRESS, PSYCHOLOGICAL; SWIMMING; TIGHT JUNCTION PROTEINS;

EID: 85035343391     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/s41593-017-0010-3     Document Type: Article

References (52)

1. Ménard, C., Pfau, M. L., Hodes, G. E. & Russo, S. J. Immune and neuroendocrine mechanisms of stress vulnerability and resilience. Neuropsychopharmacology 42, 62-80 (2017).
2. Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R. & Walters, E. E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey replication. Arch. Gen. Psychiatry 62, 617-627 (2005).
3. Seligman, F. & Nemeroff, C. B. The interface of depression and cardiovascular disease: therapeutic implications. Ann. NY Acad. Sci. 1345, 25-35 (2015).
4. Carney, R. M. & Freedland, K. E. Depression and coronary heart disease. Nat. Rev. Cardiol. 14, 145-155 (2017).
5. Wood, S. K. Individual differences in the neurobiology of social stress: implications for depression-cardiovascular disease comorbidity. Curr. Neuropharmacol. 12, 205-211 (2014).
6. Huffman, J. C., Celano, C. M., Beach, S. R., Motiwala, S. R. & Januzzi, J. L. Depression and cardiac disease: epidemiology, mechanisms, and diagnosis. Cardiovasc. Psychiatry Neurol. 2013, 695925 (2013).
7. Hodes, G. E., Kana, V., Menard, C., Merad, M. & Russo, S. J. Neuroimmune mechanisms of depression. Nat. Neurosci. 18, 1386-1393 (2015).
8. Barnes, J., Mondelli, V. & Pariante, C. M. Genetic contributions of inflammation to depression. Neuropsychopharmacology 42, 81-98 (2017).
9. Dantzer, R. Cytokine, sickness behavior, and depression. Immunol. Allergy Clin. North Am. 29, 247-264 (2009).
10. Miller, A. H. & Raison, C. L. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat. Rev. Immunol. 16, 22-34 (2016).
11. Hodes, G. E. et al. Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress. Proc. Natl. Acad. Sci. USA 111, 16136-16141 (2014).
12. Powell, N. D. et al. Social stress up-regulates inflammatory gene expression in the leukocyte transcriptome via β-adrenergic induction of myelopoiesis. Proc. Natl. Acad. Sci. USA 110, 16574-16579 (2013).
13. Heidt, T. et al. Chronic variable stress activates hematopoietic stem cells. Nat. Med. 20, 754-758 (2014).
14. Wohleb, E. S., Powell, N. D., Godbout, J. P. & Sheridan, J. F. Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior. J. Neurosci. 33, 13820-13833 (2013).
15. Weber, M. D., Godbout, J. P. & Sheridan, J. F. Repeated social defeat, neuroinflammation, and behavior: monocytes carry the signal. Neuropsychopharmacology 42, 46-61 (2017).
16. Esposito, P. et al. Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res. 888, 117-127 (2001).
17. Sántha, P. et al. Restraint stress-induced morphological changes at the blood-brain barrier in adult rats. Front. Mol. Neurosci. 8, 88 (2016).
18. Friedman, A. et al. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat. Med. 2, 1382-1385 (1996).
19. Sharma, H. S. & Dey, P. K. Impairment of blood-brain barrier (BBB) in rat by immobilization stress: role of serotonin (5-HT). Indian J. Physiol. Pharmacol. 25, 111-122 (1981).
20. Niklasson, F. & Agren, H. Brain energy metabolism and blood-brain barrier permeability in depressive patients: analyses of creatine, creatinine, urate, and albumin in CSF and blood. Biol. Psychiatry 19, 1183-1206 (1984).
21. Roszkowski, M. & Bohacek, J. Stress does not increase blood-brain barrier permeability in mice. J. Cereb. Blood Flow Metab. 36, 1304-1315 (2016).
22. Günzel, D. & Yu, A. S. Claudins and the modulation of tight junction permeability. Physiol. Rev. 93, 525-569 (2013).
23. Nitta, T. et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 161, 653-660 (2003).
24. Meltzer, H., Vostanis, P., Ford, T., Bebbington, P. & Dennis, M. S. Victims of bullying in childhood and suicide attempts in adulthood. Eur. Psychiatry 26, 498-503 (2011).
25. Berton, O. & Nestler, E. J. New approaches to antidepressant drug discovery: beyond monoamines. Nat. Rev. Neurosci. 7, 137-151 (2006).
26. Ménard, C., Hodes, G. E. & Russo, S. J. Pathogenesis of depression: Insights from human and rodent studies. Neuroscience 321, 138-162 (2016).
27. Golden, S. A., Covington, H. E. III, Berton, O. & Russo, S. J. A standardized protocol for repeated social defeat stress in mice. Nat. Protoc. 6, 1183-1191 (2011).
28. Russo, S. J. & Nestler, E. J. The brain reward circuitry in mood disorders. Nat. Rev. Neurosci. 14, 609-625 (2013).
29. Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929-11947 (2014).
30. Zhang, Y. et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 89, 37-53 (2016).
31. Hodes, G. E. et al. Sex differences in nucleus accumbens transcriptome profiles associated with susceptibility versus resilience to subchronic variable stress. J. Neurosci. 35, 16362-16376 (2015).
32. Golden, S. A. et al. Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression. Nat. Med. 19, 337-344 (2013).
33. Campbell, M. et al. Systemic low-molecular weight drug delivery to pre-selected neuronal regions. EMBO Mol. Med. 3, 235-245 (2011).
34. McKim, D.B. et al. Microglial recruitment of IL-1β-producing monocytes to brain endothelium causes stress-induced anxiety. Mol. Psychiatry https://doi.org/10.1038/mp.2017.64 (2017).
35. Saederup, N. et al. Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. PLoS One 5, e13693 (2010).
36. Mizutani, M. et al. The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood. J. Immunol. 188, 29-36 (2012).
37. Ginhoux, F. & Jung, S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat. Rev. Immunol. 14, 392-404 (2014).
38. Maes, M. et al. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9, 853-858 (1997).
39. Dowlati, Y. et al. A meta-analysis of cytokines in major depression. Biol. Psychiatry 67, 446-457 (2010).
40. Kiraly, D. D. et al. Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome. Transl. Psychiatry 7, e1065 (2017).
41. Coppen, A. J. Abnormality of the blood-cerebrospinal fluid barrier of patients suffering from a depressive illness. J. Neurol. Neurosurg. Psychiatry 23, 156-161 (1960).
42. Hambardzumyan, D., Gutmann, D. H. & Kettenmann, H. The role of microglia and macrophages in glioma maintenance and progression. Nat. Neurosci. 19, 20-27 (2016).
43. Shichita, T. et al. Pivotal role of cerebral interleukin-17-producing γδT cells in the delayed phase of ischemic brain injury. Nat. Med. 15, 946-950 (2009).
44. Golden, S. A. et al. Basal forebrain projections to the lateral habenula modulate aggression reward. Nature 534, 688-692 (2016).
45. Mishra, V. et al. Primary blast causes mild, moderate, severe and lethal TBI with increasing blast overpressures: experimental rat injury model. Sci. Rep. 6, 26992 (2016).
46. Keaney, J. et al. Autoregulated paracellular clearance of amyloid-β across the blood-brain barrier. Sci. Adv. 1, e1500472 (2015).
47. Campbell, M. et al. RNAi-mediated reversible opening of the blood-brain barrier. J. Gene Med. 10, 930-947 (2008).
48. Doyle, S. L. et al. IL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degeneration. Sci. Transl. Med. 6, 230ra44 (2014).
49. Wälchli, T. et al. Quantitative assessment of angiogenesis, perfused blood vessels and endothelial tip cells in the postnatal mouse brain. Nat. Protoc. 10, 53-74 (2015).
50. Blank, T. et al. Brain endothelial-and epithelial-specific interferon receptor chain 1 drives virus-induced sickness behavior and cognitive impairment. Immunity 44, 901-912 (2016).
51. Janssen, W. G. et al. Cellular and synaptic distribution of NR2A and NR2B in macaque monkey and rat hippocampus as visualized with subunit-specific monoclonal antibodies. Exp. Neurol. 191 (Suppl. 1), S28-S44 (2005).
52. Armulik, A. et al. Pericytes regulate the blood-brain barrier. Nature 468, 557-561 (2010).